Robert Borchert
SVP of Investor and Corporate Communication
Replay available
Privia Health Group, Inc. (NASDAQ: PRVA) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.

SVP of Investor and Corporate Communication
Chief Executive Officer
Chief Financial Officer
Analyst, Epicor ISI
Analyst, KeyBank
Analyst, Barclays
Analyst, Needham & Company
Analyst, Choice Securities
Analyst
Analyst
Analyst, UBS
Analyst, Citizens
Analyst, Piper Sandler
Analyst, Citi
Analyst, BTIG
Analyst, William Blair
Hello and welcome to the Previa Health third quarter 25 results conference call. Please note that this call is being recorded. You will have the opportunity to ask questions to our speakers later on during the community session. If you would like to ask a question by the time, please press bar one on your telephone keypad. Thank you. I'd like to hand the call over to Robert Borchert, SVP of Investor and Corporate Communication. Please go ahead. Thank you, Chris, and good morning, everyone. Joining me are Parth Mehrotra, our Chief Executive Officer, and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed through the Investor Relations section of PriviaHealth.com, along with today's financial press release and slide presentation. Following our prepared comments, we will open the line for questions. Please limit yourself to one question only and return to the queue if you have a follow-up so we can get to as many questions as possible. The financial results reported today are preliminary and are not final until our Form 10Q for the third quarter and nine-month period ended September 30, 2025, is filed with the Securities and Exchange Commission. Some of the statements we will make today are forward-looking in nature, based on our current expectations and view of our business as of November 6, 2025. Such statements, including those related to our future financial and operating performance and future business plans and objectives, are subject to risks and uncertainties that may cause actual results to differ materially. As a result, these statements should be considered along with the cautionary statements in today's press release and the risk factors described in our company's most recent SEC filings. Finally, we refer to certai...